By Femtech Insider Menopause, News, Pharma January 8, 2024 ShareTwitterFacebookPinterest-circled Bayer Announces Positive Phase III Results for Non-Hormonal Treatment in Menopause-Related Vasomotor Symptoms
By Femtech Insider Ecosystem, Medical Device, News January 8, 2024 ShareTwitterFacebookPinterest-circled Gynesonics’ Non-Invasive Uterine Fibroid Treatment Gains Official Recognition with Establishment of New CPT Code
By Kathrin Folkendt Digital Health, Ecosystem, News, Pharma, Trend Watch January 8, 2024 ShareTwitterFacebookPinterest-circled Eli Lilly’s LillyDirect: Implications for Direct-to-Consumer Women’s Health Startups
By Kathrin Folkendt Ecosystem, Fertility, News, Opinion, Reproductive Health January 8, 2024 ShareTwitterFacebookPinterest-circled Kindbody’s Growth Ambitions Spotlight Tension Between Venture Capital and Patient Care
By Femtech Insider Acquisition, DTC, Menopause, News January 5, 2024 ShareTwitterFacebookPinterest-circled Dr. Reddy’s Acquires Menopause Supplement Brand MenoLabs from Amyris in Chapter 11 Auction
By Femtech Insider News, Reproductive Health January 5, 2024 ShareTwitterFacebookPinterest-circled Contraline’s First-in-Human Clinical Trial Shows Promise for Novel Male Contraceptive
By Femtech Insider Biotech, Investment, News January 5, 2024 ShareTwitterFacebookPinterest-circled Heranova Raises $13.5M for Novel Non-Invasive Diagnostics and Treatment of Endometriosis and Bacterial Vaginosis
By Femtech Insider Biotech, Endometriosis, News January 5, 2024 ShareTwitterFacebookPinterest-circled Hera Biotech to Acquire Endometriosis Diagnostic Assets from Scailyte in Move Towards Non-Surgical Diagnosis
